How does hyperprolactinaemia related to prolactinoma increase the risk of osteoporosis?
['Hyperprolactinaemia related to prolactinoma significantly (more than functional hyperprolactiaemia) increases the risk of osteopenia, osteoporosis and bone fractures.", "INTRODUCTION Osteopenia and osteoporosis because of hyperprolactinaemia caused by prolactinoma may be followed by an increased risk of fracture.", "In conclusion, men with prolactinoma have high prevalence of osteopenia and osteoporosis.", "Humans with prolactinoma are at risk for osteoporosis.", "Osteopenia and osteoporosis because of hyperprolactinaemia caused by prolactinoma may be followed by an increased risk of fracture.", "The relative risk for developing osteoporosis in women with prolactinoma was found to be 4.5, indicating that hyperprolactinemia in women is a major risk factor for osteoporosis..", "In the premenopausal women, patients with prolactinoma or craniopharyngioma are often accompanied with osteopenia or osteoporosis, and disease duration and hypogonadism are the risk factors of bone loss in prolactinoma."]']
Hyperprolactinaemia related to prolactinoma significantly increases the risk of osteopenia, osteoporosis, and bone fractures. Men with prolactinoma have a high prevalence of osteopenia and osteoporosis. Humans with prolactinoma are at risk for osteoporosis. The relative risk for developing osteoporosis in women with prolactinoma was found to be 4.5, indicating that hyperprolactinemia in women is a major risk factor for osteoporosis. In premenopausal women, patients with prolactinoma or craniopharyngioma are often accompanied by osteopenia or osteoporosis, with disease duration and hypogonadism being risk factors for bone loss in prolactinoma.
[]